Research Studies
Study Title
CReATe Consortium: TRIAL READY Study
Enrollment Status
Active - Not Recruiting
Principal Investigators
Michael Benatar, MD, PhD
Study Type
Observational
Goals
- Validate leading biomarker candidates for potential prognostic, disease progression, and pharmacodynamic purposes
Enrolling
Controls (no longer recruiting), ALS patients (no longer recruiting)
Eligibility
Click to Expand
Controls:
- Age 18+
- Never diagnosed with (and not at a particular risk of developing) ALS or an ALS related disorder
- Able and willing to comply with study procedures
Affected (not currently recruiting):
- Age 18+
- Clinical diagnosis of ALS or an ALS related disorder
- Willing to undergo C9ORF72 screening and to learn the results
- Able and willing to comply with other study procedures
Study Involvement
Click to Expand
Controls: 5 half-day study visits at UMiami (or another study site) over a 1-year period
- Family and medical history review
- Blood, urine, and (optional) CSF collection
- Breathing test
- Neuropsychological assessment
- Questionnaires/surveys
- Neurological exam (one-time)
Affected: (No longer recruiting)
Contact
Links
Primary Funding Source
NIH
Related Publications
Click to Expand
No items found
Related Presentations & Lectures
Click to Expand
No items found